M O17 (Oxybutynin chloride extended release 15 mg)

Pill imprint M O17 has been identified as Oxybutynin chloride extended release 15 mg.

Oxybutynin is used in the treatment of overactive bladder; urinary incontinence; hyperhidrosis; dysuria; prostatitis and belongs to the drug class urinary antispasmodics. There is no proven risk in humans during pregnancy. Oxybutynin 15 mg is not subject to the Controlled Substances Act.

See also related documents.

Images for M O17 (Oxybutynin chloride extended release 15 mg)

Oxybutynin chloride extended release 15 mg M O17  Front
Oxybutynin chloride extended release 15 mg M O17  Back
Oxybutynin chloride extended release 15 mg M O17
Oxybutynin chloride extended release
Imprint:
M O17
Strength:
15 mg
Color:
Gray
Size:
8.00 mm
Shape:
Round
Availability:
Rx and/or OTC
Drug Class:
Urinary antispasmodics
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Mylan Pharmaceuticals Inc.
National Drug Code (NDC):
00378-6015
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
54868-5743 Physicians Total Care Inc (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Pill Identifier

Search by Imprint, Shape or Color

Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...

Search by Drug Name

Search by National Drug Codes (NDC)

Hide
(web4)